Anoto Welcomes News of Additional UK Funding to Accelerate Technology Revolution

AnotoAnoto Group, the creator of Digital Pen and Paper technologies, today announced its appreciation of Monday's announcement from the UK Prime Minister and Health Secretary where they set out plans to invest £140 million into the NHS, so that nurses and midwives can spend more time with patients.

In the proposals, it was announced that £100 million will be offered to the NHS for nurses and midwives to spend on new technology that will free up time for patient care and help make essential patient details instantly available on the ward, at the bedside or in the community. "Digital pens" - that is Anoto's main business offer - was explicitly mentioned as an example of the new technology in question.

Anoto's digital pen technology is already widely used by many UK NHS Trusts for its benefits in accurate capturing of patient data into Electronic Health Record (EHR) systems. The technology enables healthcare providers to digitize information with minimal user retraining or technical expertise, while reducing implementation costs. Earlier this year, Anoto's digital pen technology was referenced in a whitepaper issued by the UK Department of Health, describing successful use of digital pens by midwives operating under Portsmouth NHS Hospitals Trust.

"We are greatly encouraged to hear that the Prime Minister and Health Secretary have set out plans to invest an additional £100 million in modernising NHS processes, so that nurses and midwives can embrace emerging technologies. This will enable them to spend more time with patients doing the job that really matters, whilst reducing paperwork," said Stein Revelsby, CEO of Anoto Group AB. "This investment will ensure that NHS Trusts throughout the UK will be able to benefit from our technology."

"Not only can new technology put the power back in the hands of nurses and midwives, and enable a swifter, more comprehensive understanding of a patient's care and conditions. The technology also saves unnecessary data entry, reduces the risk of data errors and data loss, and ensures that the information captured can be made immediately available for authorized healthcare professionals," added Revelsby.

Related news article:

About Anoto Group
Anoto Group is the company behind and world leading in the unique technology for digital pen and paper, which enables fast and reliable transmission of handwritten text into a digital format. Anoto operates through a global partner network that focuses on user-friendly solutions for efficient capture, transmission and storage of data within different business segments, e.g. healthcare, bank and finance, transport and logistics and education. The Anoto Group has around 100 employees and is headquartered in Lund (Sweden). The company also has offices in Guildford and Wetherby (UK), Boston (US) and Tokyo (Japan). The Anoto share is traded on the Small Cap list of NASDAQ OMX Stockholm under the ticker ANOT.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...